FLNA and Alzheimer disease: The authors have published their findings that simufilam, a small novel molecule suggested for clinical use in Alzheimer’s disease (AD), restores a deleterious conformation of filamin A (FLNA), which is a large intracellular scaffolding protein, as indicated by changes in isoelectric focusing points [1].